Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains. Read more about Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domains.
Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis. Read more about Selective ablation of primary and paracrine senescent cells by targeting iron dyshomeostasis.
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer. Read more about Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.
Coordinating transcription and replication to mitigate their conflicts in early Drosophila embryos. Read more about Coordinating transcription and replication to mitigate their conflicts in early Drosophila embryos.
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection. Read more about Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection.
Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis. Read more about Inhibition of HCK in myeloid cells restricts pancreatic tumor growth and metastasis.
Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. Read more about Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer. Read more about GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis. Read more about Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis.
Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling. Read more about Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling.
